Today’s microbiome research is revealing the critical role of archaea in maintaining stable microbial ecosystems in the human gut. Among these organisms, Methanobrevibacter smithii is the most abundant archaeon in the human gut microbiome and plays a central role in microbial metabolism and ecosystem balance.
TwentyGreen SA develops scalable anaerobic bioprocess technologies enabling scaleable cultivation of beneficial human gut archaea. Our platform focuses on the controlled fermentation and production of Methanobrevibacter smithii biomass to unlock new applications in microbiome therapeutics, diagnostics and nutritional science.
Our platform is designed to unlock new applications across microbiome science and biotechnology, including:
1. Development of archaeal therapeutics for microbiome-related diseases
2. Support for microbiome diagnostics and precision nutrition through our sister company ARKAIYA SA at EPFL Innovation Park
3. Industrial bioprocess development for anaerobic gut microorganisms
4. Provision of archaeal strains and biomass for advanced microbiome research